Paratek Pharmaceuticals, Inc.

Home » Paratek Pharmaceuticals, Inc.

Secondary

Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics based upon tetracycline chemistry.

Symbol

PRTK

Last Closing Price
$17.67

Shares
2,900,000

Effective Date
January 18, 2018

Underwriters
BTIG

To view the prospectus for Paratek Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253